Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets

Chronic immune-mediated inflammatory diseases (IMIDs), usually accompanied by cardiovascular disease and neoplasias, are now prevailed worldwide. The limited efficacy of current therapeutics and a proportion of non-responders are linked to missing aspects in their pathophysiology at the molecular an...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Fformat: Online
Iaith:Saesneg
Cyhoeddwyd: MDPI - Multidisciplinary Digital Publishing Institute 2023
Pynciau:
Mynediad Ar-lein:ONIX_20231130_9783036592763_150
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
_version_ 1869523731018153984
collection Directory of Open Access Books
description Chronic immune-mediated inflammatory diseases (IMIDs), usually accompanied by cardiovascular disease and neoplasias, are now prevailed worldwide. The limited efficacy of current therapeutics and a proportion of non-responders are linked to missing aspects in their pathophysiology at the molecular and cellular levels. High-throughput single- and multi-omics approaches and their combinations are expected to pinpoint the key players underlying IMIDs’ establishment and/or progression, thus suggesting potential therapeutic targets and biomarkers. This Reprint gathered 13 papers presenting recent relevant data related to the assessment of CVD risk in RA, tailored therapeutics in RA-interstitial lung disease, IgG4-related RA, and Sjögren’s syndrome, enabling early identification of PsA and improving outcomes in patients’ with psoriasis. Also, novel non-invasive biomarkers for endoscopic activity and mucosal healing in ulcerative colitis, IBD, and cell-death-associated inflammatory syndromes are proposed. Moreover, a certain subset of telocytes is suggested as the pilot governor of epithelial behavior in preneoplastic gastric lesions, a newer member of IL-1 family, as it is a critical partner in lung adenocarcinoma, while distinct transcriptomic signatures and pathway profiles in human melanocytes corresponding to different Staphylococcal superantigenic enterotoxins are possible targets for therapeutic intervention in cases of toxic shocks. Lastly, Tregs- and dendritic cell-based IMID biomarkers are recommended to enable at more efficient, personalized, and precise treatment strategies.
format Online
id doab-20.500.12854ir-128698
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1286982024-03-31T13:10:01Z Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets Christodoulou, Maria-Ioanna arthritis rheumatoid immunoglobulin G immune system inflammation proteins proteomics rheumatoid arthritis periodontal disease cardiovascular disease biomarker ulcerative colitis gelsolin mucosal healing interstitial lung disease biomarkers treatment superantigens gene expression transcriptional dynamics staphylococcal enterotoxins SEB SEA TSST-1 toxins biological networks clustering functional pathways time–course analysis cDNA microarray human melanocytes cell death apoptosis necroptosis pyroptosis ubiquitin LUBAC OTULIN A20 autoimmunity human genetics epigenetics endoscopy imaging laboratory testing Sjogren’s syndrome patient stratification clinical relevance multi-omics psoriasis methylation histone ncRNAs immune-mediated inflammatory disorders autoimmune diseases immune regulation dendritic cells regulatory T cells omics therapeutic targeting chronic inflammation psoriatic diseases psoriatic arthritis data integration interleukin (IL-)37 lung adenocarcinoma survival infiltration rates FoxL1+-telocytes epithelial–mesenchymal interaction BMP signaling extracellular matrix mechanical microenvironment matrisome thema EDItEUR::M Medicine and Nursing Chronic immune-mediated inflammatory diseases (IMIDs), usually accompanied by cardiovascular disease and neoplasias, are now prevailed worldwide. The limited efficacy of current therapeutics and a proportion of non-responders are linked to missing aspects in their pathophysiology at the molecular and cellular levels. High-throughput single- and multi-omics approaches and their combinations are expected to pinpoint the key players underlying IMIDs’ establishment and/or progression, thus suggesting potential therapeutic targets and biomarkers. This Reprint gathered 13 papers presenting recent relevant data related to the assessment of CVD risk in RA, tailored therapeutics in RA-interstitial lung disease, IgG4-related RA, and Sjögren’s syndrome, enabling early identification of PsA and improving outcomes in patients’ with psoriasis. Also, novel non-invasive biomarkers for endoscopic activity and mucosal healing in ulcerative colitis, IBD, and cell-death-associated inflammatory syndromes are proposed. Moreover, a certain subset of telocytes is suggested as the pilot governor of epithelial behavior in preneoplastic gastric lesions, a newer member of IL-1 family, as it is a critical partner in lung adenocarcinoma, while distinct transcriptomic signatures and pathway profiles in human melanocytes corresponding to different Staphylococcal superantigenic enterotoxins are possible targets for therapeutic intervention in cases of toxic shocks. Lastly, Tregs- and dendritic cell-based IMID biomarkers are recommended to enable at more efficient, personalized, and precise treatment strategies. 2023-11-30T20:44:29Z 2023-11-30T20:44:29Z 2023 book ONIX_20231130_9783036592763_150 9783036592763 9783036592770 https://directory.doabooks.org/handle/20.500.12854/128698 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/8162 https://mdpi.com/books/pdfview/book/8162 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-9277-0 10.3390/books978-3-0365-9277-0 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036592763 9783036592770 246 Basel open access
spellingShingle arthritis
rheumatoid
immunoglobulin G
immune system
inflammation
proteins
proteomics
rheumatoid arthritis
periodontal disease
cardiovascular disease
biomarker
ulcerative colitis
gelsolin
mucosal healing
interstitial lung disease
biomarkers
treatment
superantigens
gene expression
transcriptional dynamics
staphylococcal enterotoxins
SEB
SEA
TSST-1
toxins
biological networks
clustering
functional pathways
time–course analysis
cDNA microarray
human melanocytes
cell death
apoptosis
necroptosis
pyroptosis
ubiquitin
LUBAC
OTULIN
A20
autoimmunity
human genetics
epigenetics
endoscopy
imaging
laboratory testing
Sjogren’s syndrome
patient stratification
clinical relevance
multi-omics
psoriasis
methylation
histone
ncRNAs
immune-mediated inflammatory disorders
autoimmune diseases
immune regulation
dendritic cells
regulatory T cells
omics
therapeutic targeting
chronic inflammation
psoriatic diseases
psoriatic arthritis
data integration
interleukin (IL-)37
lung adenocarcinoma
survival
infiltration rates
FoxL1+-telocytes
epithelial–mesenchymal interaction
BMP signaling
extracellular matrix
mechanical microenvironment
matrisome
thema EDItEUR::M Medicine and Nursing
Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets
title Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets
title_full Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets
title_fullStr Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets
title_full_unstemmed Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets
title_short Omics Approaches to Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets
title_sort omics approaches to immune mediated inflammatory diseases towards novel biomarkers and potential therapeutic targets
topic arthritis
rheumatoid
immunoglobulin G
immune system
inflammation
proteins
proteomics
rheumatoid arthritis
periodontal disease
cardiovascular disease
biomarker
ulcerative colitis
gelsolin
mucosal healing
interstitial lung disease
biomarkers
treatment
superantigens
gene expression
transcriptional dynamics
staphylococcal enterotoxins
SEB
SEA
TSST-1
toxins
biological networks
clustering
functional pathways
time–course analysis
cDNA microarray
human melanocytes
cell death
apoptosis
necroptosis
pyroptosis
ubiquitin
LUBAC
OTULIN
A20
autoimmunity
human genetics
epigenetics
endoscopy
imaging
laboratory testing
Sjogren’s syndrome
patient stratification
clinical relevance
multi-omics
psoriasis
methylation
histone
ncRNAs
immune-mediated inflammatory disorders
autoimmune diseases
immune regulation
dendritic cells
regulatory T cells
omics
therapeutic targeting
chronic inflammation
psoriatic diseases
psoriatic arthritis
data integration
interleukin (IL-)37
lung adenocarcinoma
survival
infiltration rates
FoxL1+-telocytes
epithelial–mesenchymal interaction
BMP signaling
extracellular matrix
mechanical microenvironment
matrisome
thema EDItEUR::M Medicine and Nursing
topic_facet arthritis
rheumatoid
immunoglobulin G
immune system
inflammation
proteins
proteomics
rheumatoid arthritis
periodontal disease
cardiovascular disease
biomarker
ulcerative colitis
gelsolin
mucosal healing
interstitial lung disease
biomarkers
treatment
superantigens
gene expression
transcriptional dynamics
staphylococcal enterotoxins
SEB
SEA
TSST-1
toxins
biological networks
clustering
functional pathways
time–course analysis
cDNA microarray
human melanocytes
cell death
apoptosis
necroptosis
pyroptosis
ubiquitin
LUBAC
OTULIN
A20
autoimmunity
human genetics
epigenetics
endoscopy
imaging
laboratory testing
Sjogren’s syndrome
patient stratification
clinical relevance
multi-omics
psoriasis
methylation
histone
ncRNAs
immune-mediated inflammatory disorders
autoimmune diseases
immune regulation
dendritic cells
regulatory T cells
omics
therapeutic targeting
chronic inflammation
psoriatic diseases
psoriatic arthritis
data integration
interleukin (IL-)37
lung adenocarcinoma
survival
infiltration rates
FoxL1+-telocytes
epithelial–mesenchymal interaction
BMP signaling
extracellular matrix
mechanical microenvironment
matrisome
thema EDItEUR::M Medicine and Nursing
url ONIX_20231130_9783036592763_150